SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Jubilant Ingrevia zooms after its arm inks pact to produce Agro Intermediate

03 Oct 2024 Evaluate

Jubilant Ingrevia is currently trading at Rs. 809.55, up by 34.35 points or 4.43% from its previous closing of Rs. 775.20 on the BSE.

The scrip opened at Rs. 751.05 and has touched a high and low of Rs. 836.95 and Rs. 751.05 respectively. So far 276881 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 836.95 on 03-Oct-2024 and a 52 week low of Rs. 407.00 on 01-Nov-2023.

Last one week high and low of the scrip stood at Rs. 836.95 and Rs. 725.85 respectively. The current market cap of the company is Rs. 12901.77 crore.

The promoters holding in the company stood at 51.47%, while Institutions and Non-Institutions held 20.62% and 27.90% respectively.

Jubilant Ingrevia’s wholly owned subsidiary -- Jubilant Agro Sciences (JASL) has entered into an agreement with a leading Agrochemical Company (Customer) to produce an Agro Intermediate for one of the key Agro actives of the Customer.

The overall consideration will paid based on the revenue of around $300 million plus from supplies of the Agro intermediate to the Customer, over a period of next few years after commencement of production. 

Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers.


Jubilant Ingrevia Share Price

626.00 3.90 (0.63%)
05-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3415.65
Tata Chemicals 719.40
SRF 2704.90
Pidilite Inds. 1476.50
Deepak Nitrite 1679.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×